Efficacy of Valganciclovir in the Treatment of Cytomegalovirus Disease in Kidney and Pancreas Transplant Recipients

2006 ◽  
Vol 38 (10) ◽  
pp. 3673-3675 ◽  
Author(s):  
F.L. Luan ◽  
P. Chopra ◽  
J. Park ◽  
S. Norman ◽  
D. Cibrik ◽  
...  
Keyword(s):  
Pancreas Transplant ◽  
Transplant Recipients ◽  
Cytomegalovirus Disease

CYTOMEGALOVIRUS DISEASE RECURRENCE AFTER GANCICLOVIR TREATMENT IN KIDNEY AND KIDNEY-PANCREAS TRANSPLANT RECIPIENTS

1999 ◽  
Vol 67 (1) ◽  
pp. 94-97 ◽  
Author(s):  
Abhinav Humar ◽  
Marc Uknis ◽  
Cassandra Carlone-Jambor ◽  
Rainer W. Gruessner ◽  
David L. Dunn ◽  
...  
Keyword(s):  
Disease Recurrence ◽  
Pancreas Transplant ◽  
Transplant Recipients ◽  
Cytomegalovirus Disease ◽  
Ganciclovir Treatment

A Pilot Study of an Intensified Ganciclovir Dosing Strategy for Treatment of Cytomegalovirus Disease in Kidney and/or Pancreas Transplant Recipients

2021 ◽  
Author(s):  
Margaret R Jorgenson ◽  
Jillian L Descourouez ◽  
Glen E Leverson ◽  
Christopher M Saddler ◽  
Jeannina A Smith ◽  
...  
Keyword(s):  
Pilot Study ◽  
Pancreas Transplant ◽  
Transplant Recipients ◽  
Cytomegalovirus Disease ◽  
Dosing Strategy

Tacrolimus for simultaneous kidney-pancreas transplant recipients

2006 ◽  
Author(s):  
Shu Shi Huang ◽  
Na Zhao ◽  
Shengfu Li ◽  
Dan Long ◽  
Xin Duan ◽  
...  
Keyword(s):  
Pancreas Transplant ◽  
Transplant Recipients

A Single-Center Experience With Tacrolimus LCP (Envarsus XR) in Pancreas Transplant Recipients

2017 ◽  
Vol 52 (4) ◽  
pp. 392-396
Author(s):  
L. Kerstenetzky ◽  
J. L. Descourouez ◽  
M. R. Jorgenson ◽  
D. C. Felix ◽  
D. A. Mandelbrot ◽  
...  
Keyword(s):  
Pancreas Transplant ◽  
Transplant Recipients ◽  
Single Center ◽  
Single Center Experience

scholarly journals Impact of valganciclovir prophylaxis duration on cytomegalovirus disease in high‐risk donor seropositive/recipient seronegative heart transplant recipients

2020 ◽  
Vol 22 (3) ◽  
Author(s):  
Hannah Imlay ◽  
Allison O. Dumitriu Carcoana ◽  
Cynthia E. Fisher ◽  
Beatrice Wong ◽  
Robert M. Rakita ◽  
...  
Keyword(s):  
High Risk ◽  
Heart Transplant ◽  
Transplant Recipients ◽  
Cytomegalovirus Disease ◽  
Heart Transplant Recipients

COST EFFECTIVE MEASURES TO ADMINISTER THYMOGLOBULIN® FOR INDUCTION THERAPY IN PANCREAS TRANSPLANT RECIPIENTS.

2000 ◽  
Vol 69 (Supplement) ◽  
pp. S408 ◽  
Author(s):  
Anne M. Wiland ◽  
Jeffrey C. Fink ◽  
Benjamin Philosophe ◽  
Alan Farney ◽  
Eugene J. Schweitzer ◽  
...  
Keyword(s):  
Induction Therapy ◽  
Cost Effective ◽  
Pancreas Transplant ◽  
Transplant Recipients

Management of leukopenia in kidney and pancreas transplant recipients

2008 ◽  
Vol 22 (6) ◽  
pp. 822-828 ◽  
Author(s):  
Erica L. Hartmann ◽  
Mandy Gatesman ◽  
Julie Roskopf-Somerville ◽  
Robert Stratta ◽  
Alan Farney ◽  
...  
Keyword(s):  
Pancreas Transplant ◽  
Transplant Recipients

Pancreas Allograft Biopsies in the Management of Pancreas Transplant Recipients: Histopathologic Review and Clinical Correlations

2007 ◽  
Vol 131 (8) ◽  
pp. 1192-1199
Author(s):  
Lillian W. Gaber
Keyword(s):  
Pancreas Transplantation ◽  
Therapeutic Option ◽  
Pancreas Transplant ◽  
Close Monitoring ◽  
Transplant Recipients ◽  
Systemic Complications ◽  
Histologic Evaluation ◽  
Insulin Dependent ◽  
Pancreas Allograft ◽  
End Stage

Abstract Context.—Pancreas transplantation has become a therapeutic option for patients with type 1 diabetes mellitus who are in end-stage renal failure. It also is indicated for a subset of nonuremic, insulin-dependent diabetics who experience extreme difficulties in maintaining proper glucose homeostasis by insulin therapy that compromises their productivity and safety. Objective.—To provide a review of the literature and expert experiences for understanding the histologic findings in pancreas transplantation. Data Sources.—The published literature between 1990 and 2005 was reviewed for this report. Additionally, personal files of the author were used, along with biopsy slides that were used for figures. Conclusions.—Pancreas transplantation reestablishes the physiologic state of insulin secretion, and pancreas transplant recipients are able to maintain a state of long-term euglycemia and are less likely to be exposed to hyperglycemia and its systemic complications. Key to the success of transplantation is the scrupulous management and close monitoring of the pancreas transplant recipients. To that end, histologic evaluation of pancreas allografts assumed a pivotal role in management of pancreas allograft dysfunction episodes, and in some centers surveillance biopsies are used to monitor immunologically high-risk situations.

Sign in / Sign up

Export Citation Format

Share Document